VRTX
Vertex Pharmaceuticals IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$110.28B
P/E Ratio
25.77
EPS
$16.86
Beta
0.30
52W High
$507.92
52W Low
$362.50
50-Day MA
$440.29
200-Day MA
$434.75
Dividend Yield
—
Profit Margin
35.50%
Forward P/E
22.88
PEG Ratio
1.63
About Vertex Pharmaceuticals Inc
Vertex Pharmaceuticals, Inc. is an American biopharmaceutical company based in Boston, Massachusetts.
Fundamentals
| Revenue (TTM) | $12.22B |
| Gross Profit (TTM) | $6.65B |
| EBITDA | $4.98B |
| Operating Margin | 38.10% |
| Return on Equity | 24.20% |
| Return on Assets | 12.10% |
| Revenue/Share (TTM) | $47.91 |
| Book Value | $76.18 |
| Price-to-Book | 5.70 |
| Price-to-Sales (TTM) | 9.03 |
| EV/Revenue | 8.6 |
| EV/EBITDA | 21.08 |
| Quarterly Earnings Growth (YoY) | 61.40% |
| Quarterly Revenue Growth (YoY) | 7.80% |
| Shares Outstanding | $253.81M |
| Float | $253.02M |
| % Insiders | 0.20% |
| % Institutions | 97.85% |
Historical Volatility
HV 10-Day
25.13%
HV 20-Day
21.43%
HV 30-Day
19.19%
HV 60-Day
30.31%
HV Rank
4.4%
Volatility is currently expanding
Analyst Ratings
Consensus ($548.10 target)
5
Strong Buy21
Buy5
Hold1
SellMore HEALTHCARE Stocks
Data last updated: 5/25/2026